JP2010523476A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010523476A5 JP2010523476A5 JP2009552756A JP2009552756A JP2010523476A5 JP 2010523476 A5 JP2010523476 A5 JP 2010523476A5 JP 2009552756 A JP2009552756 A JP 2009552756A JP 2009552756 A JP2009552756 A JP 2009552756A JP 2010523476 A5 JP2010523476 A5 JP 2010523476A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- substituted
- carbonyl
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 14
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 13
- 150000001875 compounds Chemical class 0.000 claims description 10
- 229910052736 halogen Inorganic materials 0.000 claims description 7
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 7
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- 150000002367 halogens Chemical class 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 229910052731 fluorine Inorganic materials 0.000 claims description 3
- 125000001424 substituent group Chemical group 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 25
- 239000003814 drug Substances 0.000 claims 10
- 238000004519 manufacturing process Methods 0.000 claims 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 6
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims 6
- 201000010099 disease Diseases 0.000 claims 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 5
- 229920001184 polypeptide Polymers 0.000 claims 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims 5
- 125000001072 heteroaryl group Chemical group 0.000 claims 4
- 108700028369 Alleles Proteins 0.000 claims 3
- 239000000006 Nitroglycerin Substances 0.000 claims 3
- 230000002255 enzymatic effect Effects 0.000 claims 3
- 229960003711 glyceryl trinitrate Drugs 0.000 claims 3
- 230000000302 ischemic effect Effects 0.000 claims 3
- -1 nitroglycerin compound Chemical class 0.000 claims 3
- 150000003254 radicals Chemical class 0.000 claims 3
- 231100000331 toxic Toxicity 0.000 claims 3
- 230000002588 toxic effect Effects 0.000 claims 3
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 claims 2
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 claims 2
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 claims 2
- 206010002383 Angina Pectoris Diseases 0.000 claims 2
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 claims 2
- 230000001154 acute effect Effects 0.000 claims 2
- 230000001684 chronic effect Effects 0.000 claims 2
- 238000007918 intramuscular administration Methods 0.000 claims 2
- 238000001990 intravenous administration Methods 0.000 claims 2
- 238000007920 subcutaneous administration Methods 0.000 claims 2
- 125000003107 substituted aryl group Chemical group 0.000 claims 2
- ZBRHSFGIAYSWFQ-UHFFFAOYSA-N 2,6-dichloro-n-[(4-methoxyphenyl)methyl]benzamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)C1=C(Cl)C=CC=C1Cl ZBRHSFGIAYSWFQ-UHFFFAOYSA-N 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 230000000035 biogenic effect Effects 0.000 claims 1
- 208000031225 myocardial ischemia Diseases 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 231100000419 toxicity Toxicity 0.000 claims 1
- 230000001988 toxicity Effects 0.000 claims 1
- 102000009645 Mitochondrial Aldehyde Dehydrogenase Human genes 0.000 description 1
- 108010009513 Mitochondrial Aldehyde Dehydrogenase Proteins 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90596307P | 2007-03-08 | 2007-03-08 | |
| PCT/US2008/003092 WO2008112164A2 (en) | 2007-03-08 | 2008-03-07 | Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014194188A Division JP2015061836A (ja) | 2007-03-08 | 2014-09-24 | ミトコンドリアアルデヒドデヒドロゲナーゼ−２モジュレーター及びその使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010523476A JP2010523476A (ja) | 2010-07-15 |
| JP2010523476A5 true JP2010523476A5 (en:Method) | 2014-11-20 |
Family
ID=39760277
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009552756A Pending JP2010523476A (ja) | 2007-03-08 | 2008-03-07 | ミトコンドリアアルデヒドデヒドロゲナーゼ−２モジュレーター及びその使用方法 |
| JP2014194188A Pending JP2015061836A (ja) | 2007-03-08 | 2014-09-24 | ミトコンドリアアルデヒドデヒドロゲナーゼ−２モジュレーター及びその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014194188A Pending JP2015061836A (ja) | 2007-03-08 | 2014-09-24 | ミトコンドリアアルデヒドデヒドロゲナーゼ−２モジュレーター及びその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20110105602A2 (en:Method) |
| EP (1) | EP2126574B1 (en:Method) |
| JP (2) | JP2010523476A (en:Method) |
| KR (1) | KR20090117950A (en:Method) |
| CN (1) | CN101669030B (en:Method) |
| AU (1) | AU2008226947B2 (en:Method) |
| CA (1) | CA2679882C (en:Method) |
| WO (1) | WO2008112164A2 (en:Method) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110105602A2 (en) | 2007-03-08 | 2011-05-05 | Daria Mochly-Rosen | Mitochondrial Aldehyde Dehydrogenase-2 Modulators and Methods of Use Thereof |
| US8354435B2 (en) | 2008-09-08 | 2013-01-15 | The Board Of Trustees Of The Leland Stanford Junior University | Modulators of aldehyde dehydrogenase activity and methods of use thereof |
| WO2010062308A1 (en) * | 2008-10-28 | 2010-06-03 | The Board Of Trustees Of The Leland Stanford Junior University | Modulators of aldehyde dehydrogenase and methods of use thereof |
| WO2012082862A2 (en) * | 2010-12-14 | 2012-06-21 | Beth Israel Deaconess Medical Center | Androgen receptor inhibitors and methods of use thereof |
| WO2012149106A1 (en) | 2011-04-29 | 2012-11-01 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for increasing proliferation of adult salivary stem cells |
| TWI567061B (zh) | 2011-07-01 | 2017-01-21 | 吉李德科學股份有限公司 | 用於治療成癮之化合物 |
| EP2887968A2 (en) * | 2012-08-24 | 2015-07-01 | The Board of Trustees of the Leland Stanford Junior University | Methods and compositions for treating pain |
| US9670162B2 (en) | 2013-03-14 | 2017-06-06 | The Board Of Trustees Of The Leland Stanford Junio | Mitochondrial aldehyde dehyrogenase-2 modulators and methods of use thereof |
| CN103191103A (zh) * | 2013-04-15 | 2013-07-10 | 中南大学 | 乙醛脱氢酶激活物alda-1的合成方法及其用途 |
| CN103923077B (zh) * | 2013-07-05 | 2016-03-02 | 高尔医药科技(上海)有限公司 | 两种乙醛脱氢酶激动剂、其制备方法及用途 |
| JP6261278B2 (ja) * | 2013-10-16 | 2018-01-17 | 国立大学法人広島大学 | アルデヒドデヒドロゲナーゼの活性を増強するための医薬組成物 |
| WO2015084731A1 (en) * | 2013-12-02 | 2015-06-11 | The Board Of Trustees Of The Leland Stanford Junior University | Aldehyde dehydrogenase inhibitors and methods of use thereof |
| WO2015127137A1 (en) * | 2014-02-19 | 2015-08-27 | Aldea Pharmaceuticals, Inc. | Mitochondrial aldehyde dehydrogenase 2 (aldh2) binding polycyclic amides and their use for the treatment of cancer |
| FR3054564B1 (fr) | 2016-07-28 | 2018-08-31 | Advanced Biodesign | Substrat specifique d'une isoenzyme de l'aldh |
| WO2019098288A1 (ja) * | 2017-11-15 | 2019-05-23 | 学校法人 慶應義塾 | 抗腫瘍剤及び配合剤 |
| BR112020014237A2 (pt) | 2018-01-31 | 2020-12-08 | Eisai R&D Management Co., Ltd. | Ativador de aldh2 |
| CN108864034A (zh) * | 2018-06-04 | 2018-11-23 | 中国人民解放军第二军医大学 | 酰胺类醛脱氢酶激动剂、其合成方法及用途 |
| CN111909138A (zh) * | 2019-05-09 | 2020-11-10 | 上海仕谱生物科技有限公司 | 抑制tdg活性的化合物 |
| TW202110437A (zh) * | 2019-05-23 | 2021-03-16 | 美商希諾瓦有限責任公司 | 用於酒精誘發之皮膚潮紅之治療及緩解的組成物及方法 |
| US12509423B2 (en) | 2020-11-02 | 2025-12-30 | Alchemedicine, Inc. | Compound, aldehyde dehydrogenase 2 activating agent, pharmaceutical composition, and therapeutic and/or prophylactic drug |
| IL313420A (en) | 2022-04-22 | 2024-08-01 | Alchemedicine Inc | Compound, Aldehyde Dehydrogenase 2 Activator, Pharmaceutical Preparation and Treatment and/or Prophylactic Drug |
Family Cites Families (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2319808A (en) | 1939-08-31 | 1943-05-25 | Squibb & Sons Inc | Sterol derivatives and process for producing same |
| JPH01203351A (ja) | 1988-02-05 | 1989-08-16 | Mitsui Petrochem Ind Ltd | １，４−ジヒドロキシナフタレン誘導体および医薬 |
| JPH023351A (ja) | 1988-06-16 | 1990-01-08 | Oki Electric Ind Co Ltd | 印刷装置 |
| US4861891A (en) * | 1988-08-31 | 1989-08-29 | Pfizer Inc. | Antidepressant N-substituted nicotinamide compounds |
| JPH03184973A (ja) | 1989-12-14 | 1991-08-12 | Rooman Kogyo:Kk | 放射線障害防護剤 |
| US5260323A (en) | 1990-06-28 | 1993-11-09 | Hoechst Aktiengesellschaft | 2,4- and 2,5-substituted pyridine-N-oxides, processes for their preparation and their use |
| DE4201047A1 (de) * | 1992-01-17 | 1993-07-22 | Bayer Ag | Substituierte isoxazolcarbonsaeureamide |
| US5272137A (en) * | 1992-02-14 | 1993-12-21 | Mcneil-Pfc, Inc. | Aqueous pharmaceutical suspension for pharmaceutical actives |
| JP2994182B2 (ja) | 1992-07-23 | 1999-12-27 | 石原産業株式会社 | アミド系化合物又はその塩、それらの製造方法及びそれらを含有する有害動物防除剤 |
| JP3833281B2 (ja) | 1995-02-03 | 2006-10-11 | 日本曹達株式会社 | ２，６−ジクロロイソニコチン酸ベンジルアミド誘導体及び植物病害防除剤 |
| WO1997010223A1 (en) | 1995-09-15 | 1997-03-20 | Pharmacia & Upjohn Company | Aminoaryl oxazolidinone n-oxides |
| US6072050A (en) | 1996-06-11 | 2000-06-06 | Pioneer Hi-Bred International, Inc. | Synthetic promoters |
| FR2751645B1 (fr) | 1996-07-29 | 1998-12-24 | Sanofi Sa | Amines pour la fabrication de medicaments destines a empecher la proliferation de cellules tumorales |
| CN1327443A (zh) | 1997-10-31 | 2001-12-19 | 艾文蒂斯药品有限公司 | 取代的酰苯胺化合物 |
| JP2002511386A (ja) * | 1997-12-22 | 2002-04-16 | イーライ・リリー・アンド・カンパニー | アミド形成反応のための触媒およびその方法 |
| EP1080069B1 (en) * | 1998-04-20 | 2003-03-19 | Fujisawa Pharmaceutical Co., Ltd. | Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase |
| AR019190A1 (es) | 1998-07-08 | 2001-12-26 | Sod Conseils Rech Applic | Derivados de 2-aminopiridinas, productos intermedios para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y su uso para preparar medicamentos |
| US6780883B2 (en) | 1998-11-05 | 2004-08-24 | Warner-Lambert Company | Amide inhibitors of microsomal triglyceride transfer protein |
| WO2000031060A1 (en) | 1998-11-25 | 2000-06-02 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Scavenger compounds |
| GB9919558D0 (en) | 1999-08-18 | 1999-10-20 | Hoechst Schering Agrevo Gmbh | Fungicidal compounds |
| AU1466001A (en) * | 1999-11-05 | 2001-05-14 | Phase-1 Molecular Toxicology | Methods of determining individual hypersensitivity to an agent |
| WO2001079489A2 (en) | 2000-04-18 | 2001-10-25 | Millennium Pharmaceuticals, Inc. | 39228, a human alcohol dehydrogenase and uses therefor |
| US7179912B2 (en) | 2000-09-01 | 2007-02-20 | Icos Corporation | Materials and methods to potentiate cancer treatment |
| BR0113931A (pt) | 2000-09-15 | 2004-01-13 | Anormed Inc | Compostos heterocìclicos ligantes receptores de quimiocinas |
| US7141590B2 (en) | 2000-12-29 | 2006-11-28 | Ucb Sa | Pharmaceutical uses and synthesis of nicotinanilide-N-oxides |
| DOP2002000332A (es) | 2001-02-14 | 2002-08-30 | Warner Lambert Co | Inhibidores de piridina de metaloproteinasas de la matriz |
| US6678516B2 (en) | 2001-05-21 | 2004-01-13 | Nokia Corporation | Method, system, and apparatus for providing services in a privacy enabled mobile and Ubicom environment |
| EP1402890B1 (en) | 2001-06-08 | 2008-01-09 | Institute of Medicinal Molecular Design, Inc. | Sulfonamide derivatives |
| JPWO2003030937A1 (ja) * | 2001-10-05 | 2005-01-20 | 小野薬品工業株式会社 | ミトコンドリアルベンゾジアゼピン受容体アンタゴニストからなるストレス疾患の治療剤 |
| DE10149674A1 (de) | 2001-10-09 | 2003-04-24 | Apogepha Arzneimittel Gmbh | Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung |
| US20030100034A1 (en) | 2001-10-16 | 2003-05-29 | Millennium Pharmaceuticals, Inc. | 9136, a human aldehyde dehydrogenase family member and uses therefor |
| KR20040077884A (ko) | 2002-01-31 | 2004-09-07 | 화이자 프로덕츠 인코포레이티드 | （3-｛〔（4-3급-뷰틸-벤질）-（피리딘-3-설폰일）-아미노〕-메틸｝-페녹시）-아세트산의 대사산물 |
| JP4595059B2 (ja) | 2002-04-18 | 2010-12-08 | 株式会社医薬分子設計研究所 | アミド誘導体 |
| GB0215650D0 (en) * | 2002-07-05 | 2002-08-14 | Cyclacel Ltd | Bisarylsufonamide compounds |
| KR20050049485A (ko) | 2002-09-06 | 2005-05-25 | 엘란 파마슈티칼스, 인크. | 1,3-디아미노-2-히드록시프로판 전구약물 유도체 |
| EP1402887A1 (en) * | 2002-09-18 | 2004-03-31 | Jerini AG | New compounds for the inhibition of undesired cell proliferation and use thereof |
| EP1402888A1 (en) * | 2002-09-18 | 2004-03-31 | Jerini AG | The use of substituted carbocyclic compounds as rotamases inhibitors |
| US7135575B2 (en) | 2003-03-03 | 2006-11-14 | Array Biopharma, Inc. | P38 inhibitors and methods of use thereof |
| US7022850B2 (en) | 2003-05-22 | 2006-04-04 | Bristol-Myers Squibb Co. | Bicyclicpyrimidones and their use to treat diseases |
| JP4359754B2 (ja) | 2003-07-03 | 2009-11-04 | 三菱瓦斯化学株式会社 | 基板の洗浄剤 |
| JP2007528717A (ja) | 2003-07-21 | 2007-10-18 | オンコセラピー・サイエンス株式会社 | 結腸直腸癌を診断する方法 |
| WO2005011561A2 (en) | 2003-08-04 | 2005-02-10 | Labcoat, Ltd. | Stent coating apparatus and method |
| GB0318814D0 (en) | 2003-08-11 | 2003-09-10 | Smithkline Beecham Corp | Novel compounds |
| FR2861074B1 (fr) | 2003-10-17 | 2006-04-07 | Sanofi Synthelabo | Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique |
| FR2861071B1 (fr) | 2003-10-17 | 2006-01-06 | Sanofi Synthelabo | Derives de n-[phenyl(alkylpiperidin-2-yl) methyl]benzamide, leur prepartation et leur application en therapeutique |
| WO2005057213A1 (en) | 2003-12-09 | 2005-06-23 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for modulating mitochondrial aldehyde dehydrogenase-2 |
| WO2005084392A2 (en) * | 2004-03-03 | 2005-09-15 | Convivia | 4-methylpyrazole formulations for inhibiting ethanol intolerance |
| JP2007538024A (ja) * | 2004-05-19 | 2007-12-27 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | アミロイドベータペプチドのレベル変化に関連する疾患及び状態の治療方法及び新規エノールカルボキサミド化合物 |
| CN1749415A (zh) * | 2004-09-15 | 2006-03-22 | 上海人类基因组研究中心 | 硝酸甘油治疗急性心绞痛疗效检测方法和试剂盒 |
| US7456194B2 (en) | 2004-11-12 | 2008-11-25 | Bristol-Myers Squibb Company | Imidazo-fused oxazolo [4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
| US7888374B2 (en) | 2005-01-28 | 2011-02-15 | Abbott Laboratories | Inhibitors of c-jun N-terminal kinases |
| DOP2006000051A (es) | 2005-02-24 | 2006-08-31 | Lilly Co Eli | Inhibidores de vegf-r2 y métodos |
| GEP20115230B (en) | 2005-09-23 | 2011-06-10 | Pfizer Prod Inc | Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4 |
| AU2006331765A1 (en) | 2005-12-22 | 2007-07-05 | Wyeth | Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3(2H)-isoquinolones and use thereof as kinase inhibitor |
| JP2009531364A (ja) | 2006-03-28 | 2009-09-03 | ノバルティス アクチエンゲゼルシャフト | アミド誘導体およびｇタンパク質関連疾患の処置のためのそれらの使用 |
| EP2727585A1 (en) | 2006-05-16 | 2014-05-07 | Takeda Pharmaceutical Company Limited | In-vivo screening method |
| US20080003585A1 (en) | 2006-06-29 | 2008-01-03 | Bio-Rad Laboratories, Inc., A Corporation Of The State Of Delaware | Purification and amplification of nucleic acids in a microfluidic device |
| KR20090033417A (ko) | 2006-07-27 | 2009-04-03 | 씨브이 쎄러퓨틱스, 인코포레이티드 | 중독의 치료에서의 ａｌｄｈ-2 저해제 |
| PE20080906A1 (es) | 2006-08-17 | 2008-07-05 | Kemia Inc | Derivados heteroarilo como inhibidores de citocina |
| US8927715B2 (en) | 2006-08-25 | 2015-01-06 | Vitae Pharmaceuticals, Inc. | Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 |
| ATE507205T1 (de) | 2006-12-11 | 2011-05-15 | Genetics Co Inc | Aromatische 1,4-di-carboxylamide und deren verwendung |
| WO2008082487A2 (en) | 2006-12-20 | 2008-07-10 | Schering Corporation | Novel jnk inhibitors |
| US20080200461A1 (en) | 2007-02-20 | 2008-08-21 | Cropsolution, Inc. | Modulators of acetyl-coenzyme a carboxylase and methods of use thereof |
| WO2008108991A1 (en) * | 2007-03-02 | 2008-09-12 | Merck & Co., Inc. | Bipyridine carboxamide orexin receptor antagonists |
| US20110105602A2 (en) | 2007-03-08 | 2011-05-05 | Daria Mochly-Rosen | Mitochondrial Aldehyde Dehydrogenase-2 Modulators and Methods of Use Thereof |
| CA2709784A1 (en) | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| EP2300433A4 (en) | 2008-06-04 | 2012-03-07 | Ambrilia Biopharma Inc | HIV INTEGRASE INHIBITORS FROM PYRIDOXIN |
| PE20110136A1 (es) | 2008-06-27 | 2011-03-17 | Novartis Ag | Compuestos organicos |
| US8354435B2 (en) * | 2008-09-08 | 2013-01-15 | The Board Of Trustees Of The Leland Stanford Junior University | Modulators of aldehyde dehydrogenase activity and methods of use thereof |
| WO2010062308A1 (en) * | 2008-10-28 | 2010-06-03 | The Board Of Trustees Of The Leland Stanford Junior University | Modulators of aldehyde dehydrogenase and methods of use thereof |
-
2008
- 2008-03-07 US US12/044,870 patent/US20110105602A2/en not_active Abandoned
- 2008-03-07 EP EP08726601.1A patent/EP2126574B1/en not_active Not-in-force
- 2008-03-07 WO PCT/US2008/003092 patent/WO2008112164A2/en not_active Ceased
- 2008-03-07 CA CA2679882A patent/CA2679882C/en not_active Expired - Fee Related
- 2008-03-07 KR KR1020097020216A patent/KR20090117950A/ko not_active Ceased
- 2008-03-07 CN CN200880013697.9A patent/CN101669030B/zh not_active Expired - Fee Related
- 2008-03-07 JP JP2009552756A patent/JP2010523476A/ja active Pending
- 2008-03-07 AU AU2008226947A patent/AU2008226947B2/en not_active Ceased
-
2011
- 2011-08-22 US US13/214,937 patent/US9102651B2/en active Active
-
2014
- 2014-09-24 JP JP2014194188A patent/JP2015061836A/ja active Pending
- 2014-10-21 US US14/520,098 patent/US9315484B2/en active Active